Investor profile
Cambridge Enterprise has backed 36 European tech companies across 40 funding rounds between 2014 and 2026, joining rounds totalling €391M. Most active in Healthtech and Cleantech. Data as of 5 Oct 2026.
Also recorded as: Cambridge Enterprise Ventures
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Carrick Therapeutics | Ireland | 1 | €86M |
| Nu Quantum | UK | 1 | €52M |
| Echion Tecnologies | UK | 1 | €34M |
| Echion Technologies | UK | 1 | €34M |
| Trimtech Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Carrick Therapeutics | Series A | €86M | 2016-10 |
| Nu Quantum | Other | €52M | 2025-12 |
| Echion Tecnologies | Other | €34M | 2024-06 |
| Echion Technologies |
| 1 |
| €29M |
| Gigaton | UK | 1 | €22M |
| Seprify | Switzerland | 1 | €13M |
| Reclinker | UK | 1 | €12M |
| Barocal | UK | 2 | €10M |
| PharmEnable | UK | 2 | €9.0M |
| Xampla | UK | 1 | €6.4M |
| Fluidic Analytics | UK | 1 | €6.2M |
| Regulatory Genome Development | UK | 1 | €5.5M |
| NoBACZ Healthcare | UK | 1 | €5.5M |
| Wave Photonics | UK | 1 | €5.3M |
| Carbon Re | UK | 1 | €4.8M |
| Cambridge Epigenetix | UK | 1 | €4.4M |
| Sparxell | UK | 1 | €4.2M |
| Porotech | UK | 1 | €3.5M |
| xWatts | UK | 2 | €3.5M |
| AudioTelligence | UK | 1 | €3.5M |
| Healthera | UK | 2 | €3.4M |
| Semarion | UK | 1 | €3.3M |
| Paragraf | UK | 1 | €3.3M |
| Evoralis | UK | 1 | €3.0M |
| Spirea | UK | 1 | €2.9M |
| Silicon MicroGravity | UK | 1 | €2.7M |
| BKwai | UK | 1 | €2.6M |
| Trismik | UK | 1 | €2.5M |
| Zetta Genomics | UK | 1 | €2.1M |
| Series B |
| €34M |
| 2024-06 |
| Trimtech Therapeutics | Seed | €29M | 2025-03 |
| Gigaton | Series A | €22M | 2026-06 |
| Seprify | Series A | €13M | 2026-03 |
| Barocal | Seed | €8.6M | 2026-05 |
| PharmEnable | Seed | €6.9M | 2023-05 |
| Xampla | Other | €6.4M | 2024-01 |
